Diverse production of interferons α, β, and γ by airway leukocytes of asthmatics with regard to cigarette smoking and corticosteroid treatment

Journal of Interferon and Cytokine Research

Volumn 27, Issue 6, 2007, Pages 463-470

  Liebhart, Jerzy ^a   Cembrzynska Nowak, Monika ^b   Kulczak, Aleksandra ^a   Siemieniec, Iwona ^b  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; BUDESONIDE; CORTICOSTEROID; GAMMA INTERFERON;

ADULT; ARTICLE; ASTHMA; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOSTEROID THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERFERON PRODUCTION; LYMPHOCYTE ACTIVATION; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM;

ADRENAL CORTEX HORMONES; ADULT; ASTHMA; BLOOD CELL COUNT; CASE-CONTROL STUDIES; FEMALE; HEALTH; HUMANS; INTERFERON TYPE II; INTERFERON-ALPHA; INTERFERON-BETA; INTERFERONS; LEUKOCYTES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SMOKING;

EID: 34250809501     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2007.0102     Document Type: Article

References (61)

1. Goodbourn S, Didcock L, Randall RE. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J. Gen. Virol. 2000;81:2341-2364.
2. Le Page C, Genin P, Baines MG, Hiscott J. Interferon activation and innate immunity. Rev. Immunogenet. 2000;2:374-386.
3. Sen GC, Lengyel P. The interferon system. A bird's eye of its biochemistry. J. Biol. Chem. 1992;267:5017-5020.
4. + T cells. Allergy Clin. Immunol. 2005;116:205-212.
5. Tilg H, Kaser A. Type I interferons and their therapeutic role in Th2-regulated inflammatory disorders. Expert Opin. Biol. Ther. 2004;4:469-481.
6. Chung KF, Barnes PJ. Cytokines in asthma. Thorax 1999;54:825-857.
7. Chung KF. Anti-inflammatory cytokines in asthma and allergy: interleukin-10, interleukin-12, interferon-gamma. Mediators Inflamm. 2001;10:51-59.
8. Nagai T, Devergne O, Mueller TF, Perkins DL, van Seventer JM, van Seventer GA. Timing of IFN-beta exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-beta-mediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation. J. Immunol. 2003;171:5233-5243.
9. Bosca L, Bodelon OG, Hortelano S, Casellas A, Bosch F. Anti-inflammatory action of type I interferons deduced from mice expressing interferon β. Gene Ther. 2000;7:817-825.
10. Aksharifi M, Lobigs M, Regner M, Lee E, Koskinen A, Mulbacher A. Type I interferons trigger systemic, partial lymphocyte activation in response to viral infections. J. Immunol. 2005;175:4635-4640.
11. Teixeira LK, Fonseca BP, Barboza BA, Viola JP. The role of interferon-gamma on immune and allergic responses. Mem. Inst. Oswaldo Cruz 2005;100:137-144.
12. Gosset P, Tsicopulos A, Wallaert B, Joseph M, Capron A, Tonnel AB. Tumor necrosis factor-a and interleukin-6 production by human mononuclear phagocytes from allergic asthmatics after IgE-dependent stimulation. Am. Rev. Respir. Dis. 1992;146:768-774.
13. Davies RJ, Wang J, Abdelaziz MM, Calderon MA, Khair O, Devalia JL, Rusznak C. New insights into the understanding of asthma. Chest 1997;111:2S-10S.
14. Thomas PS. Tumor necrosis factor-α: the role of this multifunctional cytokine in asthma. Immunol. Cell Biol. 2001;79:132-140.
15. Cembrzynska-Nowak M, Szklarz E, Inglot AD, Teodorczyk-Injeyan JA. Elevated release of tumor necrosis factor-alpha and interferon-gamma by bronchoalveolar leukocytes from patients with bronchial asthma. Am. Rev. Respir. Dis. 1993;47:291-295.
16. Cembrzynska-Nowak M, Liebhart J, Panaszek B, Dobek R, Bienkowska M, Szklarz E. TNF-α, IL-6 and IFN-γ secreted by bronchoalveolar leukocytes isolated from patients with bronchial asthma, complicated by fungal airway infections. Arch. Immunol. Ther. Exp. 1998;46:381-386.
17. Liebhart J, Cembrzynska-Nowak M, Bienkowska M, Liebhart E, Dobek R, Zaczynska E, Panaszek B, Obojski A, Malolepszy J. Relevance of the selected cytokine release (TNF-α , IL-6, IFN-γ and IFN-α) to the exacerbation of bronchial asthma from airway mycotic infections. Predominant role of IFN-α? J. Invest. Allergol. Clin. Immunol. 2002;3:182-191.
18. Billiau A, Dijkmans R. Interferon-gamma: mechanism of action and therapeutic potential. Biochem. Pharmacol. 1990;40:1433-1439.
19. Leonard C, Tormey, V, BurkeC, Poulter LW. Allergen-induced cytokine production in atopic disease and its relationship to disease severity. Am. J. Respir. Cell. Mol. Biol. 1997;17:368-375.
20. Litonjua AA, Sparrow D, Guevarra L, O'Connor GT, Weiss ST, Tollerud DJ. Serum interferon-gamma is associated with longitudinal decline in lung function among asthmatic patients; the Normative Aging Study. Ann. Allergy Asthma Immunol. 2005;90:422-428.
21. Antoniuo KM, Ferdoutsis E, Bouros D. Interferons and their application in the diseases of the lung. Chest 2003;123:209-216.
22. Simon HU, Seelbach H, Ehmann R, Schmitz M. Clinical and immunological effects of low-dose IFN-α treatment in patients with corticosteroid- resistant asthma. Allergy 2003;58:1250-1255.
23. Althuis MD, Sexton M, Prybylski D. Cigarette smoking and asthma symptom severity among adult asthmatics. J. Asthma 1999;36: 257-264.
24. Chalmers GW, Macleod KJ, Little SA, Thompson LJ, McSharry CP, Thompson NC. Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma. Thorax 2002;57:226-230.
25. Chaundhuri R, Livingston E, McMahon AD, Thomson L, Borland W, Thomson NC. Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma. Am. J. Respir. Crit. Care Med. 2003;168:1308-1311.
26. Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. Eur. Respir. J. 2004;24:822-833.
27. Boulet LP, Lemiere C, Archambault F, Carrier G, Descary MC, Deschesnes F. Smoking and asthma: critical and radiological features, lung function, and airway inflammation. Chest 2006;129: 661-668.
28. Global Initiative for Asthma. National Heart, Lung and Blood Institute/World Health Organization Workshop Report. Bethesda, MD: 1995 (updated 2002), No 95-3659.
29. Fahy JV, Kim KW, Liu J, Boushey HA. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J. Allergy Clin. Immunol. 1995;95:843-852.
30. Pang GT, Clancy RL, Reeves GE. Isolation functional of T cells from human sputum. Clin. Exp. Immunol. 1995;102:642-648.
31. Byron KA, Varigos GA, Wootton AM. IL-4 production is increased in cigarette smokers. Clin. Exp. Immunol. 1994;95:333-336.
32. Hagiwara E, Takahashi KI, Okubo T, Ohno S, Ueda A, Aoki A, Odagiri S, Ishigatsubo Y. Cigarette smoking depletes cells spontaneously secreting Th(1) cytokines in the human airway. Cytokine 2001;14:121-126.
33. McCrea KA, Ensor JE, Nall K, Bleecker ER, Hasday JD. Altered cytokine regulation in the lungs of cigarette smokers. Am. J. Respir. Crit. Care Med. 1994;150:696-703.
34. Siroux V, Pin I, Oryszczyn MP, Le Moual N, Kauffmann F. Relationships of active smoking to asthma and asthma severity in the EGEA study. Epidemiological study on the Genetics and Environment of Asthma. Eur. Respir. J. 2000;5:470-477.
35. Necela BM, Cidlowski JA. Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells. Proc. Am. Thorac. Soc. 2004;1:239-246.
36. Adcock IA, Ito K, Barnes PJ. Glucocorticoids. Effects on gene transcription Proc. Am. Thorac. Soc. 2004;1:247-254.
37. Okahira S, Nishikawa S, Akazawa T, Seya T, Matsumoto M. Interferon-beta induction through toll-like receptor 3 depends on double-stranded RNA structure. DNA Cell. Biol. 2005;24:614-623.
38. Kirchhoff S, Wilhelm D, Angel P, Hauser H. NFkappaB activation is required for interferon regulatory factor-1-mediated interferon beta induction. Eur. J. Biochem. 1999;261:546-554.
39. Ulrik CS, Lange P. Cigarette smoking and asthma Monaldi Arch. Chest Dis. 2001;56:349-353.
40. Georas SN. Inhaled glucocorticoids, lymphocytes, and dendritic cells in asthma and obstructive lung disease. Proc. Am. Thorac. Soc. 2004;1:215-221.
41. Ahn KS, Aggarwal BB. Transcription factor NF-kappa: a sensor for smoke and stress signals Ann. NY Acad. Sci. 2005;1056: 218-233.
42. Karimi K, Sarir H, Mortaz E, Smit JJ, Hosseini H, de Kimpe S, Folkerts G. Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages Respir. Res. 2006; 7:66-77.
43. Laan M, Bozinovski S, Anderson GP. Cigarette smoke inhibits lipopolysaccharide-induced production of inflammatory cytokines by suppressing the activation of activator protein-1 in bronchial epithelial cells. J. Immunol. 2004;173:4164-4170.
44. Vassallo R, Tamada K, Lau JS, Kroening PR, Chen L. Smoke extract suppresses human dendritic cell function leading to preferential induction of Th-2 priming. J. Immunol. 2005;175:2684-2691.
45. Von der Ohe M, Altstaedt J, Gross U, Rink L. Human neutrophils produce macrophage inhibitory protein-1β but not type I interferons in response to viral stimulation. J. Interferon Cytokine Res. 2001;21:241-247.
46. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, Lanzavecchia A, Colonna M. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type 1 interferon Nat. Med. 1999;5:919-923.
47. Taniguchi T, Takaoka A. A weak signal for strong responses: interferon α/β revisited. Nat. Rev. Mol. Cell Biol. 2001;2:378-386.
48. Vermaelen K, Pauwels R. Pulmonary dendritic cells. Am. J. Respir. Crit. Care Med. 2005;172:530-551.
49. Iho S. Type I IFN synthesis in plasmacytoid dendritic cells J. Immunol. 2003;171:2767-2774.
50. Szabo SJ, Kim St, Costa GL, Zhang X, Fathman G, Glimcher H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000;100:655-669.
51. Höhler T, Reuss E, Adams P, Bartsch B, Weigmann B, Wörns M, Galle PR, Victor A, Neurath MF. A genetic basis for IFN-γ production and T-bet expression in humans J. Immunol. 2005;17: 5457-5462.
52. Vignola AM, Gagliardo R, Guerrera D, Chiappara G, Chanez P, Bousquet J, Bonsignore G. New evidence in inflammation in asthma. Thorax 2000;55:S59-S60.
53. Ouyang Y, Virasch N, Hao P, Aubrey MT, Mukerjee N, Bierer BE, Freed BM. Suppression of human IL-1 beta, IL-2, IFN-gamma, and TNF-α production by cigarette smoke extracts. J. Allergy Clin. Immunol. 2000;106:280-287.
54. Barnes PJ. Th2 cytokines and asthma: an introduction. Respir. Res. 2001;2:64-65.
55. Tatsis E, Schnabel A, Gross WL. Interferon-alpha treatment of four patients with the Churg-Strauss syndrome. Ann. Intern. Med. 1998;129:370-374.
56. Bentley AM, Hamid Q, Robinson DS, Schotman E, Meng Q, Assoufi B, Kay AB, Durham SR. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am. J. Respir. Crit. Care Med. 1996;153:551-556
57. Tantisira KG, Hwang ES, Raby BA, Silverman ES, Lake SL, Richter BG, Peng SL, Drazen JM, Glimcher LH, Weiss ST. TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc. Natl. Acad. Sci. USA 2004;10:18099-18104.
58. Weiss ST, Lake SL, Silverman ES, Silverman EK, Richter B, Drazen JM, Tantisira KG. Asthma steroid pharmacogenetics study strategy to identify replicated treatment responses. Proc. Am. Thorac Soc. 2004;1:364-367.
59. Frucht DM, Fukao T, Bogdan C, Schindler H, O'Shea JJ, Koyasu S. IFN-gamma production by antigen-presenting cells: mechanisms emerge. Trends Immunol. 2001;22:556-560.
60. Look DC, Rapp SR, Keller BT, Holtzman MJ. Selective induction of intracellular adhesion molecule-1 by interferon-gamma in human airway epithelial cells. Am. J. Physiol. 1992;263:L79-L87.
61. Reisinger J, Triendl A, Kuchler E, Bohle B, Krauth MT, Rauter I, Valent P, Koenig F, Valenta R, Niederberger V. IFN-gamma-enhanced allergen penetration across respiratory epithelium augments allergic inflammation. J. Allergy Clin. Immunol. 2005;115:973-981.